The inflammatory response plays a central role in the complications of congenital pulmonary airway malformations (CPAM) and severe coronavirus disease 2019 (COVID-19). The aim of this study was to evaluate the transcriptional changes induced by SARS-CoV-2 exposure in pediatric MSCs derived from pediatric lung (MSCs-lung) and CPAM tissues (MSCs-CPAM) in order to elucidate potential pathways involved in SARS-CoV-2 infection in a condition of exacerbated inflammatory response. MSCs-lung and MSCs-CPAM do not express angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TRMPSS2). SARS-CoV-2 appears to be unable to replicate in MSCs-CPAM and MSCs-lung. MSCs-lung and MSCs-CPAM maintained the expression of stemness markers MSCs-lung show an inflammatory response (IL6, IL1B, CXCL8, and CXCL10), and the activation of Notch3 non-canonical pathway; this route appears silent in MSCs-CPAM, and cytokine genes expression is reduced. Decreased value of p21 in MSCs-lung suggested no cell cycle block, and cells did not undergo apoptosis. MSCs-lung appears to increase genes associated with immunomodulatory function but could contribute to inflammation, while MSCs-CPAM keeps stable or reduce the immunomodulatory receptors expression, but they also reduce their cytokines expression. These data indicated that, independently from their perilesional or cystic origin, the MSCs populations already present in a patient affected with CPAM are not permissive for SARS-CoV-2 entry, and they will not spread the disease in case of infection. Moreover, these MSCs will not undergo apoptosis when they come in contact with SARS-CoV-2; on the contrary, they maintain their staminality profile.

SARS-CoV-2 exposed mesenchymal stromal cell from congenital pulmonary airway malformations: Transcriptomic analysis and the expression of immunomodulatory genes / A. Valeri, L. Chiricosta, A. Gugliandolo, M. Biasin, M.A. Avanzini, V. Calcaterra, G. Cappelletti, S. Carelli, G.V. Zuccotti, S. Silvestro, E. Mazzon, G. Pelizzo. - In: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. - ISSN 1661-6596. - 22:21(2021 Nov 01), pp. 11814.1-11814.17. [10.3390/ijms222111814]

SARS-CoV-2 exposed mesenchymal stromal cell from congenital pulmonary airway malformations: Transcriptomic analysis and the expression of immunomodulatory genes

M. Biasin;G. Cappelletti;S. Carelli;G.V. Zuccotti;G. Pelizzo
Ultimo
2021

Abstract

The inflammatory response plays a central role in the complications of congenital pulmonary airway malformations (CPAM) and severe coronavirus disease 2019 (COVID-19). The aim of this study was to evaluate the transcriptional changes induced by SARS-CoV-2 exposure in pediatric MSCs derived from pediatric lung (MSCs-lung) and CPAM tissues (MSCs-CPAM) in order to elucidate potential pathways involved in SARS-CoV-2 infection in a condition of exacerbated inflammatory response. MSCs-lung and MSCs-CPAM do not express angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TRMPSS2). SARS-CoV-2 appears to be unable to replicate in MSCs-CPAM and MSCs-lung. MSCs-lung and MSCs-CPAM maintained the expression of stemness markers MSCs-lung show an inflammatory response (IL6, IL1B, CXCL8, and CXCL10), and the activation of Notch3 non-canonical pathway; this route appears silent in MSCs-CPAM, and cytokine genes expression is reduced. Decreased value of p21 in MSCs-lung suggested no cell cycle block, and cells did not undergo apoptosis. MSCs-lung appears to increase genes associated with immunomodulatory function but could contribute to inflammation, while MSCs-CPAM keeps stable or reduce the immunomodulatory receptors expression, but they also reduce their cytokines expression. These data indicated that, independently from their perilesional or cystic origin, the MSCs populations already present in a patient affected with CPAM are not permissive for SARS-CoV-2 entry, and they will not spread the disease in case of infection. Moreover, these MSCs will not undergo apoptosis when they come in contact with SARS-CoV-2; on the contrary, they maintain their staminality profile.
Congenital pulmonary airway malformations; Mesenchymal stromal cell; SARS-CoV-2; Transcriptomic analysis
Settore BIO/13 - Biologia Applicata
Settore MED/04 - Patologia Generale
   Secretoma di cellule mesenchimali stromali nelle malattie croniche polmonari: validazione di un approccio innovativo per la cura della fibrosi polmonare indotta COVID 19 (LUNGCHILDMSC)
   LUNGCHILDMSC
   MINISTERO DELL'ISTRUZIONE E DEL MERITO
   FISR2020IP_02959

   Characterization of SARS-CoV-2 accessory proteins in terms of host adaptation, biochemical properties, and pharmacophore models (CORONA)
   CORONA
   FONDAZIONE CARIPLO
1-nov-2021
Article (author)
File in questo prodotto:
File Dimensione Formato  
ijms-22-11814-v2.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 2.18 MB
Formato Adobe PDF
2.18 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/883326
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 3
social impact